Pribicevic V, Skrabalo Z, Lipovac V, Trenc S, Zadjelovic J, Rajkovic Z
Int J Fertil. 1979;24(2):114-9.
The carbohydrate and lipid metabolism of 100 women using an oral contraceptive (0.5 mg norgestrel + 0.05 mg ethinyl estradiol) and of 96 women using mechanical contraceptives was monitored over a 2-year period. The women had been screened for factors known to adversely affect carbohydrate and lipid metabolism. Two-hour oral glucose tolerance tests were performed at 6-month intervals during the study; serum insulin was determined at the same intervals in half the women. Triglycerides, total cholesterol, free fatty acids, and body weight were also measured. The study showed no significant differences in lipid metabolism nor in weight gain between women using oral or mechanical contraceptives. After 6 months the fasting glucose of women using oral contraceptives was significantly decreased; at 120 minutes, glucose and insulin levels were significantly increased in comparison to women using mechanical contraceptives. A greater percentage of oral contraceptive users had borderline-abnormal oral glucose tolerance tests but the abnormalities did not persist in the same individuals during the study. The incidence of a pathological oral glucose tolerance with oral contraceptives was 1%.
在两年的时间里,对100名使用口服避孕药(0.5毫克炔诺孕酮+0.05毫克炔雌醇)的女性和96名使用机械避孕方法的女性的碳水化合物和脂质代谢进行了监测。这些女性已针对已知会对碳水化合物和脂质代谢产生不利影响的因素进行了筛查。在研究期间,每6个月进行一次两小时口服葡萄糖耐量试验;在一半的女性中,以相同的间隔测定血清胰岛素。还测量了甘油三酯、总胆固醇、游离脂肪酸和体重。研究表明,使用口服避孕药或机械避孕方法的女性在脂质代谢和体重增加方面没有显著差异。6个月后,使用口服避孕药的女性空腹血糖显著降低;与使用机械避孕方法的女性相比,在120分钟时,血糖和胰岛素水平显著升高。口服避孕药使用者中,有更大比例的人口服葡萄糖耐量试验接近异常,但在研究期间,这些异常情况并未在同一人群中持续存在。口服避孕药导致病理性口服葡萄糖耐量异常的发生率为1%。